Clinical Laboratory
A clinical laboratory is a laboratory where tests are done on clinical specimens in order to get information about the health of a patient as pertaining to the diagnosis, treatment, and prevention of disease.
Clinical laboratories are at the forefront of the personalized medicine trend. However, they are also targets for cost-cutting measures by payers, and increased regulation by CMS and FDA, making the industry a challenging one in which to succeed.
Laboratory medicine is generally divided into two sections, each of which being subdivided into multiple units. These two sections are:
- Anatomic pathology: Units included here are histopathology, cytopathology, and electron microscopy. Other disciplines pertaining to this section include anatomy, physiology, histology, pathology, and pathophysiology.
- Clinical pathology, which includes:
- Clinical Microbiology: This encompasses five different sciences. These include bacteriology, virology, parasitology, immunology, and mycology.
- Clinical Chemistry: Units under this section include instrumental analysis of blood components, enzymology, toxicology and endocrinology.
- Hematology: This section consists of automated and manual analysis of blood cells.
- Genetics is also studied along with a subspecialty known as cytogenetics.
- Reproductive biology: Semen analysis, Sperm bank and assisted reproductive technology.
Credibility of medical laboratories is paramount to the health and safety of the patients relying on the testing services provided by these labs. The international standard in use today for the accreditation of medical laboratories is ISO 15189. Under their respective approaches to laboratory licensure and accreditation, many countries have legal requirements that medical laboratories must be accredited to ISO 15189. This is not true in the United States.
In the United States, there are federal and state laws that address the licensure and accreditation of medical laboratories. Accreditation is done by the Joint Commission, College of American Pathologists, AAB (American Association of Bioanalysts), and other state and federal agencies. CLIA 88, the Clinical Laboratory Improvement Amendments, also dictate testing and personnel.
In addition, many clinical laboratories have adopted quality management programs such as Six Sigma and Lean quality to improve clinical quality, reduce turnaround time, cut costs, and boost productivity. Lean and Six Sigma are both process improvement methodologies. At a very basic level, Lean is about speed and efficiency, while Six Sigma is about precision and accuracy, leading to data-driven decisions. Lean and Six Sigma methods are finding numerous applications in anatomic pathology laboratories and pathology group practices.
Dynacare, LabCorp, IMPATH, Visible Genetics, Abbott Labs
ACTIVITY AT DYNACARE HINTS AT POSSIBLE SALE, LABCORP MAY BE BUYER With Quest Diagnostics Incorporated snapping up independent lab companies right and left in recent months, the question asked by many is “Where’s Laboratory Corporation of America?” On …
Cytyc Acquires Digene To Expand Product Line
CEO SUMMARY: Cytyc Corporation will pay more than one half billion dollars to purchase Digene, Inc., and its DNA Capture HPV test. For Cytyc, this may prove to be a strategic masterstroke. In the short term, it alters the competitive balance in the market for liquid preparation Pap testin…
How Dr. Al Nichols Changed The Lab Testing Marketplace
CEO SUMMARY: At a time when lab testing meant routine assays performed within a few miles of the collection, Albert L. Nichols, M.D. envisioned a centralized national laboratory devoted to performing specialized, highly-complex testing to clinicians everywhere. Not only did his vision bec…
ARUP Labs, ProxyMed, Unilab, Quest Diagnostics, Ventana, , Misys Molecular Diagnostics, WebMD, Varian
ARUP TO USE PROXYMED FOR BROWSER-BASED TEST ORDERS & RESULTS ARUP LABORATORIES, INC. and ProxyMed, Inc. signed an agreement that makes ProxyMed’s ProxyLabSM the preferred product for browser-based lab test ordering between physicians and ARUP’s hospi…
FNA Clinic Business Becomes Part of Unilab
CEO SUMMARY: Pathology has a new business model entering the marketplace. The goal of FNA Clinics of America, Inc. is to offer patients speedy access to the FNA procedure and provide referring physicians with a final diagnosis within hours of the FNA procedure. Unilab Corporation recogniz…
Court Orders Roche to Pay IGEN $505 Million in Damages
IT WAS A BIG COURT WIN for little IGEN International. On January 10, a jury in federal district court in Maryland decided that IGEN could terminate its licensing agreement with Roche Holding AG. The jury also awarded IGEN a total of $505 million, $105 million in com…
MedUnite, Bio-Reference Labs, X-Fin, Sunquest/Misys, Roche Holdings
MEDUNITE MOVES CLOSER TO ONLINE HEALTH TRANSACTION SERVICES MEDUNITE INC.’S PLANS TO USE the Internet for claims activity and other transaction services is moving forward. On January 17, it announced an agreement with Bio-Reference Laboratories, Inc. (BRL…
Pacificare, IBM, Keane, MedicaLogic/MedScape, WebMD, DrKoop.com
PACIFICARE BEGINS SERIOUS RESTRUCTURING TO SHIFT EMPHASIS NOT SO MANY YEARS AGO, PacifiCare Health Systems Inc. was considered the quintessential embodiment of all that was expected to be good with managed healthcare. The company’s business model was studied and copied in…
Patent Access Limits Rapid HIV Testing in USA
CEO SUMMARY: Diagnostic manufacturers will begin to face the same controversy over public access to diagnostic testing technology that has dogged pharmaceutical companies in recent years. Public health officials and the military are unhappy with how Bio-Rad and its HIV-2 licensees have fa…
DIANON Systems, United Health, Aetna, Quest Diagnostics, Orchid, AmeriPath
DIANON SYSTEMS INKS NATIONAL AGREEMENT WITH UNITEDHEALTHCARE A NEW NATIONAL AGREEMENT between DIANON Systems, Inc. and UnitedHealthcare was announced last week. The agreement allows DIANON Systems to provide pathology and genetic testing services to all the…
CURRENT ISSUE
Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.